Patient Care

Medicines that contain radioactive isotopes—known as radiopharmaceuticals—are used to treat cancer and to help physicians diagnose a wide variety of conditions through imaging. But while radiopharmaceuticals are a standard and invaluable medical tool in the field of nuclear medicine, synthesizing them can be challenging.

Vinay Chadha is the finance director of a fitness company, and exercise has always been important to him. But when the pandemic hit New York City this past March, the 37-year-old found his activities drastically curtailed—first when he fell ill with COVID-19, then by the statewide shelter-in- place order.

Health Matters spoke with Dr. Simon, an assistant professor of medicine in the Division of Infectious Diseases at Weill Cornell Medicine, to understand the different kinds of masks and why it might make sense to start double masking.

Patients with acute myeloid leukemia that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment. 

The COVID-19 vaccine rollout is underway, bringing a sense of hope — as well as many questions about safety and who should get the vaccine. To help answer these questions, NewYork-Presbyterian experts address common concerns about the new Moderna and Pfizer-BioNTech COVID-19 vaccines and explain why they are safe.

Heartbeat rhythms may be regulated by a family of enzymes called prolyl isomerases, according to a study from scientists at Weill Cornell Medicine.

The risk of dying seven years after coronary artery bypass surgery was significantly lower in men receiving multiple bypass grafts rather than single grafts, but there was no apparent difference in mortality between these methods in women.

Patient mistrust of the healthcare system, which has come under new focus during the COVID-19 pandemic, is partly the result of an increasingly consumer-oriented healthcare system, according to a new commentary by a Weill Cornell Medicine investigator.

Ovarian tumors can be made more sensitive to immunotherapy by blocking the recruitment of certain cells to the...

Seeking to advance the scope of precision medicine, Weill Cornell Medicine, NewYork-Presbyterian Hospital, and Illumina, Inc. are entering into a collaboration to sequence the complete human genomes of thousands of consenting patients. 

The immunotherapy drug pembrolizumab, known by its brand name Keytruda, is a safe and effective option for patients with locally advanced and metastatic squamous cell esophageal cancer who have already received standard chemotherapy, according to a new study co-authored by a Weill Cornell Medicine and NewYork-Presbyterian investigator.

Researchers from Weill Cornell Medicine, Cornell University and San Jose State University have identified six free planning models for estimating hospital capacity requirements when COVID-19 cases surge.

When a patient is hospitalized with COVID-19, signs of damage to the right side of the heart may indicate a greater risk of death, according to a study from investigators at Weill Cornell Medicine and NewYork-Presbyterian.

Cancer patients who contracted COVID-19 during the height of the pandemic in New York City had similar outcomes to other patients with COVID-19.

Drawing on New York’s diverse population, Weill Cornell Medicine scientists have been awarded grants from the New York Genome Center (NYGC) to study how several types of cancer differ in patients with different genetic backgrounds and point to precision treatments for groups that have been historically underrepresented in cancer research. 

It began as a spark of interest in remote healthcare, gained momentum four years ago with the introduction of a suite of digital health services, then exploded when COVID-19 strained the system, making hospital and doctor visits anything but routine. Today, telemedicine—as a panel of experts at an Oct. 1 Weill Cornell Medicine webinar agreed—is no longer a futuristic idea but an immediate and vital tool for doctors and patients alike.

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorker.

Weill Cornell Medicine investigators have received a total of $3.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of telehealth services during the COVID-19 pandemic, and to develop models that can aid in clinical decision making in the treatment of the virus.

Weill Cornell Medicine is a leader in performing a promising nonsurgical procedure for weight loss

Dr. Bishoy Faltas works to develop more effective therapies for bladder cancer, a disease that’s notoriously hard to treat—and historically under-studied